Phosphorous Monitoring May Be Optimal for Detecting Serious ICANS in Patients Receiving CAR T-Cell TherapyOctober 31st 2022
Following CAR T-cell therapy, the onset of hypophosphatemia may represent a biomarker for immune effector cell–associated neurotoxicity syndrome incidence and severity.
Oncology Nurses Need Better Resources to Help Patients With Mental Health ProblemsOctober 4th 2022
Although oncology nurses are trained to show empathy and offer support, they lack the resources to adequately care for patients with acute mental health problems.
Stephanie Jackson Unpacks Recent Advances in Leukemia TreatmentsAugust 15th 2022
Stephanie Jackson, DNP, MSN, RN, AOCNP, BMTCN, discusses the trajectory of targeted and CAR T-cell therapies such as ivosidenib and brexucabtagene autoleucel, and what nurses need to know about these treatments to be able to practice at the top of their licensure.
Nurses Adapt to New Hematology Advances and Approvals in Leukemia TreatmentAugust 8th 2022
Treatments options for various histologies of leukemia are expanding with FDA approvals for drugs such as the combination of ivosidenib/azacitidine and the CAR T-cell therapy brexucabtagene autoleucel.
NCCN Guidelines Reflect Recent Advances in Resectable NSCLCJune 2nd 2022
Updates to the NCCN guidelines for patients with resectable early-stage NSCLC now include neoadjuvant and adjuvant regimens with chemotherapy, immunotherapy, and targeted therapies, which promise to change biomarker testing practice.
Stephanie Jackson Discusses the Feasibility of a Discharge Lounge for Stem Cell Transplant UnitsMay 24th 2022
Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, discusses how collaboration between an oncology unit and discharge lounge can improve discharge times for patients who have undergone stem cell transplantation.
Stephanie Jackson on Point-of-Use Shower Filtration on an Inpatient Transplant UnitApril 30th 2022
Point-of-use shower filtration may be an effective strategy in reducing waterborne pathogens and protecting patients who underwent stem cell transplant from infection.
Quality Oncology Care: Discussing Fertility Preservation for Patients With Breast CancerMarch 7th 2022
At a presentation during the 39th Annual Miami Breast Cancer Conference, Lindsay Kroener, MD, highlighted key components related to fertility preservation for patients with breast cancer.
High Rate of High-Risk Endometrial Cancer in Black Women Demands Attention and Further Research Into Underlying DisparitiesFebruary 1st 2022
An expert from the University of California Los Angeles (UCLA) discusses the alarming rate of high-risk uterine cancers among Black women and how researchers are investigating the underlying risk factors at play.
Frontline Pembrolizumab Plus Chemo Does Not Show Superior OS Over Chemo Alone in PD-L1+ Gastric/GEJ AdenocarcinomaJanuary 21st 2022
Pembrolizumab plus chemotherapy did not induce clinically meaningful survival benefit, compared with chemotherapy alone, in patients with advanced gastric or gastroesophageal junction adenocarcinoma and a PD-L1 combined positive score of 1 or higher.
Patients With HER2+ Metastatic Breast Cancer Experience Consistent PFS Benefit With Trastuzumab DeruxtecanJanuary 14th 2022
An expert discusses the implications of a subgroup analysis of the DESTINY-BREAST03 trial, which highlighted the efficacy of trastuzumab deruxtecan in HER2-positive metastatic breast cancer.
Prescribing Considerations for Patients with Chronic LeukemiaNovember 22nd 2021
Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, Oncology Nursing News co-editor in chief, discusses the importance of NCCN guidelines in prescribing medications for patients with chronic leukemia. .